OVERVIEW
MEK-ICS has taken the lead of developing and commercializing
ventilators based on Korea’s first and unique respiratory technologies.
ventilators based on Korea’s first and unique respiratory technologies.
We are proactive in expanding the application of our respiratory care solutions developed by various research activities in order to help more patients.
This effort will allow us to expand our top-notch technologies to both hospital and homecare sectors with the presentation of various evidences on how the demographic and environmental changes have effects on respiration and health of the mankind.
MEK-ICS has a strong belief that product safety and quality of raw materials must in no way be compromised.
To this end, we have established internal systems and R&D bases satisfying the quality and safety standards for the functionality of respiratory care products. Those help us correctively understand overseas local market circumstances and build a technologically cooperative agent system, thereby contributing to MEK-ICS evolving into a global player in the respiration care market.
This effort will allow us to expand our top-notch technologies to both hospital and homecare sectors with the presentation of various evidences on how the demographic and environmental changes have effects on respiration and health of the mankind.
MEK-ICS has a strong belief that product safety and quality of raw materials must in no way be compromised.
To this end, we have established internal systems and R&D bases satisfying the quality and safety standards for the functionality of respiratory care products. Those help us correctively understand overseas local market circumstances and build a technologically cooperative agent system, thereby contributing to MEK-ICS evolving into a global player in the respiration care market.
ACHIEVEMENTS
Certification of CE, ISO etc. through continuous R&D of MEK







INVESTORS
We will contribute to improving the quality of human life through technologies and services for healthy respiration.
- Change 1,300
- % Change -3.76%
- (As of 2021/01/15 18:59)
- 33,300
- KOSPI 3,085.90
- KOSDAQ 964.44
Disclosure information
We provide you with our disclosure information.
- 권리락(유상증자) 2021-01-13
- 유상증자1차발행가액결정 2021-01-13
- [기재정정]주요사항보고서(유무상증자결정) 2021-01-13
- [기재정정]투자설명서 2021-01-13
- [발행조건확정]증권신고서(지분증권) 2021-01-13
- 투자설명서 2021-01-08